MACANDREWS SOUTH CORPORATION for MACANDREWS SOUTH CORPORATION
What was lobbied
11 issue areas, each in the filer's own words, with who lobbied on it and where.
Postal POS
Issues relating to postal service reform and rates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE ARONSON | — |
| EVAN KNISELY | — |
Budget/Appropriations BUD
Issues relating to biodefense countermeasures and funding and continuous pharmaceutical manufacturing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL GOODMAN | — |
| EVAN KNISELY | — |
Consumer Issues/Safety/Products CSP
Issues relating to the regulation of cosmetics. Issues relating to FDA regulation of sunscreen.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE ARONSON | — |
| WILL GOODMAN | — |
Aviation/Airlines/Airports AVI
HR 4880, "Improving Helicopter Safety Act of 2019", monitoring all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EVAN KNISELY | — |
Defense DEF
Public Law 116-93, Consolidated Appropriations Act, 2020, Division A-Department of Defense Appropriations Act, FY2020, regarding appropriations, authorization, and modernization of light tactical wheeled vehicles. Issues relating to international sales. Issues relating to mobile artillery capabilities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE ARONSON | — |
| WILL GOODMAN | — |
| EVAN KNISELY | — |
Gaming/Gambling/Casino GAM
Issues relating to casino supply regulation. Monitor international trade-gaming.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL GOODMAN | — |
Telecommunications TEC
Monitor Data privacy issues generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE ARONSON | — |
| WILL GOODMAN | — |
Health Issues HCR
H.R.3, Elijah Cummings Lower Drug Cost Now Act, issues relating to drug pricing transparency. H.R. 2115, Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act, issues relating to drug pricing transparency. S.2543, Prescription Drug Pricing Reduction Act of 2019, issues relating to drug pricing transparency Monitor over-the-counter monograph reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE ARONSON | — |
Animals ANI
Monitor issues relating to the regulation of cosmetic animal testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE ARONSON | — |
Tariff (miscellaneous tariff bills) TAR
Monitor Section 301 tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE ARONSON | — |
| WILL GOODMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.